114 related articles for article (PubMed ID: 1716542)
1. Serial study of CD5+ and CD5- B cell subpopulations in 335 HIV seropositive patients.
Vuillier F; Scott-Algara D; Tortevoye P; Pialoux G; Dighiero G
Clin Exp Immunol; 1991 Sep; 85(3):476-80. PubMed ID: 1716542
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
Vuillier F; Claisse JF; Vandenvelde C; Travade P; Magnac C; Chevret S; Desablens B; Binet JL; Dighiero G
Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
[TBL] [Abstract][Full Text] [Related]
3. Large-cell "mixed-phenotype" lymphoma in AIDS. Identification of a CD5-expressing subset of B-cell non-Hodgkin's lymphoma.
Mercolino TJ; Herndier B; Nolan TJ; McGrath MS
Ann N Y Acad Sci; 1992 May; 651():409-21. PubMed ID: 1376058
[TBL] [Abstract][Full Text] [Related]
4. CD5+ B lymphocytes in HIV infection: relationship to immunological progression of disease.
Sampalo A; López-Gómez M; Jiménez-Alonso J; Ortiz F; Samaniego F; Garrido F
Clin Immunol Immunopathol; 1993 Mar; 66(3):260-8. PubMed ID: 7679344
[TBL] [Abstract][Full Text] [Related]
5. B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsets.
Indraccolo S; Mion M; Zamarchi R; Veronesi A; Veronese ML; Panozzo M; Betterle C; Barelli A; Borri A; Amadori A
J Clin Immunol; 1993 Nov; 13(6):381-8. PubMed ID: 7507125
[TBL] [Abstract][Full Text] [Related]
6. CD20 and CD5 expression in B-chronic lymphocytic leukemia.
Marti GE; Faguet G; Bertin P; Agee J; Washington G; Ruiz S; Carter P; Zenger V; Vogt R; Noguchi P
Ann N Y Acad Sci; 1992 May; 651():480-3. PubMed ID: 1376065
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities in immunoregulatory CD5+ B cells precede the diagnosis of multiple myeloma.
Paglieroni T; MacKenzie MR; Caggiano V
Ann N Y Acad Sci; 1992 May; 651():486-7. PubMed ID: 1376067
[No Abstract] [Full Text] [Related]
8. Monoclonal IgM rheumatoid factor secreted by CD5-negative B cells during mixed cryoglobulinemia. Evidence for somatic mutations and intraclonal diversity of the expressed VH region gene.
Crouzier R; Martin T; Pasquali JL
J Immunol; 1995 Jan; 154(1):413-21. PubMed ID: 7527818
[TBL] [Abstract][Full Text] [Related]
9. Identification of a CD21 receptor-deficient, non-Ig-secreting peripheral B lymphocyte subset in HIV-seropositive drug abusers.
Benedetto A; Di Caro A; Camporiondo MP; Gallone D; Zaniratti S; Tozzi V; Elia G
Clin Immunol Immunopathol; 1992 Feb; 62(2):139-47. PubMed ID: 1370396
[TBL] [Abstract][Full Text] [Related]
10. CD5+ B cells are decreased in peripheral blood of patients with Crohn's disease.
Neil GA; Summers RW; Cheyne BA; Capenter C; Huang WL; Kansas GS; Waldschmidt TJ
Dig Dis Sci; 1992 Sep; 37(9):1390-5. PubMed ID: 1380423
[TBL] [Abstract][Full Text] [Related]
11. The relationship between CD5+ and CD5- B cells, immunoglobulin-secreting cells (IgSC), and CD4 T cells in human immunodeficiency virus (HIV) infection.
Spira TJ; Jones B; Ibegbu C; Lee F; Holmes R; Nahmias AJ
Ann N Y Acad Sci; 1992 May; 651():591-3. PubMed ID: 1376087
[No Abstract] [Full Text] [Related]
12. IL-10 is predominantly produced by CD19(low)CD5(+) regulatory B cell subpopulation: characterisation of CD19 (high) and CD19(low) subpopulations of CD5(+) B cells.
Lee JH; Noh J; Noh G; Choi WS; Lee SS
Yonsei Med J; 2011 Sep; 52(5):851-5. PubMed ID: 21786452
[TBL] [Abstract][Full Text] [Related]
13. B-cell subsets and platelet counts in HIV-1 seropositive subjects.
Kouri YH; Basch RS; Karpatkin S
Lancet; 1992 Jun; 339(8807):1445-6. PubMed ID: 1376384
[TBL] [Abstract][Full Text] [Related]
14. Identification of two distinct CD5- B cell subsets from human tonsils with different responses to CD40 monoclonal antibody.
Dono M; Zupo S; Masante R; Taborelli G; Chiorazzi N; Ferrarini M
Eur J Immunol; 1993 Apr; 23(4):873-81. PubMed ID: 7681401
[TBL] [Abstract][Full Text] [Related]
15. Induction of isotype switching and Ig production by CD5+ and CD10+ human fetal B cells.
Punnonen J; Aversa GG; Vandekerckhove B; Roncarolo MG; de Vries JE
J Immunol; 1992 Jun; 148(11):3398-404. PubMed ID: 1375243
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic characterization of human B-lymphocyte subpopulations, particularly human CD5+ B-lymphocyte subpopulation within the mantle zones of secondary follicles.
Abe M; Tominaga K; Wakasa H
Leukemia; 1994 Jun; 8(6):1039-44. PubMed ID: 7516026
[TBL] [Abstract][Full Text] [Related]
17. Relationship of the CD5 B cell to human tonsillar lymphocytes that express autoantibody-associated cross-reactive idiotypes.
Kipps TJ; Duffy SF
J Clin Invest; 1991 Jun; 87(6):2087-96. PubMed ID: 1710233
[TBL] [Abstract][Full Text] [Related]
18. CD5 expression in human B-cell populations.
Youinou P; Jamin C; Lydyard PM
Immunol Today; 1999 Jul; 20(7):312-6. PubMed ID: 10379049
[TBL] [Abstract][Full Text] [Related]
19. Proliferation and differentiation of human CD5+ and CD5- B cell subsets activated through their antigen receptors or CD40 antigens.
Defrance T; Vanbervliet B; Durand I; Briolay J; Banchereau J
Eur J Immunol; 1992 Nov; 22(11):2831-9. PubMed ID: 1385152
[TBL] [Abstract][Full Text] [Related]
20. CD43 and CD5 antibodies define four normal and neoplastic B-cell subsets: a three-color flow cytometric study.
Lynch EF; Jones PA; Swerdlow SH
Cytometry; 1995 Sep; 22(3):223-31. PubMed ID: 8556954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
